Master's Programme in Organic Synthesis and Medicinal Chemistry, 120 credits

This programme provides knowledge on the design, synthesis and evaluation of low-weight organic substances. It also covers protein chemistry and biomolecular design, preparing you for a career in the pharmaceutical industry.

Organic Synthesis and Medicinal Chemistry, Master's Programme

Autumn 2018, Full time 100%, Linköping

Organic Synthesis and Medicinal Chemistry, Master's Programme - Second admission round mainly for Swedish and EU/EEA students

Autumn 2018, Full time 100%, Linköping

Biologically active substances with low molecular weight represent the core of life-science research. Knowledge of molecular structures and their properties are crucial to our understanding of vast scientific areas, from pharmaceutically active compounds in designer drugs to organic electronics and their incorporation into diagnostic tools such as biosensors. Our research facilities are well equipped with all the necessary analytical and diagnostic tools found in industrial research facilities, which will advance your practical capabilities.

Organic and medicinal chemistry

This master’s programme aims to provide students with knowledge on the design, synthesis and evaluation of low molecular weight biologically active organic substances. The programme begins with courses in organic chemistry and organic synthesis, building from the basic concepts to the advanced level, followed by an introduction in medicinal chemistry and pharmaceutical technology. It also covers protein chemistry and biomolecular design, which broadens your knowledge in the field of bio-organic chemistry. A key part of the programme is a one-year degree project, undertaken either in a research group at LiU or in industry.

Syllabus and course details

A detailed syllabus, curriculum, and information on the courses you may take can be found in our study information database via the link below. Entry requirements and tuition fees can be found by selecting the plus sign at the top of the page. 

Career opportunities

Our graduates have the theoretical knowledge and the practical experience needed to work with organic synthesis in the pharmaceutical industry. Possible employers include companies ranging from research-intensive start-ups to major pharmaceutical producers with large R&D departments. Alternatively, you may continue conducting research leading to a doctoral degree.

Current research

  • Synthesis of an azide-functionalized carbohydrate derivatives for positron emission tomography (PET). PET is a nuclear medicine functional imaging technique that produces a three-dimensional image of functional processes in the body.
  • Synthesis of potassium ion channel openers. These molecules are potentially useful agents in the therapy of various diseases, such as acute stroke, epilepsy, and psychoses.
  • Synthesis and characterisation of designer drug metabolites. It is a great challenge for many forensic science researchers because there aren’t commercial available reference samples for the new drugs, and their metabolites, on the market. This project is in a collaboration with the division of analytical chemistry at the university and The National Board of Forensic Medicine (Rättsmedicinalverket, RMV).
  • Synthesis of functionalized oligothiophene derivatives with specific optical and electronic properties. By combining the features of polymers and the electro-optical properties of conjugated molecules, conjugated polymers suitable for a wide range of applications, such as solar cells, displays and biosensors are created.

Application and admission

Contact Us